Guardant Health to Participate in Upcoming Investor Conferences
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/18/2026
- Tech stocks weigh on Wall Street as Iran stalemate lifts oil, yields
- Baidu slips as Q2 results miss estimates despite growth in AI cloud business
- Nvidia or Sandisk? BofA reveals which stock is under-owned and which is crowded
- Home Depot beats estimates, reaffirms fiscal 2026 guidance
- Citi says positioning risk is shifting from short squeezes to profit-taking
- Wall Street indexes slip as oil prices rise, retail results awaited
- Micron rises as White House presses Apple to avoid Chinese memory chips
- BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
- Trump threatens to bomb Oman over Iran stance
- U.S. EV market shows signs of bottoming out: Bernstein
BTIG Reiterates Buy Rating on Guardant Health (GH)
May 23, 2024 5:54 AM EDTBTIG analyst Mark Massaro reiterated a Buy rating and $45.00 price target on Guardant Health (NASDAQ: GH).
The analyst comments "We think the stock valuation can tolerate slightly higher leverage above 6x, especially if odds improve for the yield curve to steepen... On... More
